OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:319612
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked Mendelian Susceptibility to Mycobacterial Diseases (MSMD) due to IKBKG deficiency is a rare inherited immune system disorder that makes affected individuals highly vulnerable to infections caused by mycobacteria. Mycobacteria are a group of germs that include the bacteria responsible for tuberculosis (TB) and other normally weak (low-virulence) organisms like BCG vaccine strains and environmental mycobacteria. In healthy people, the immune system can usually fight off these germs easily, but in people with this condition, the immune system cannot mount an effective defense. This condition is caused by mutations in the IKBKG gene (also known as NEMO), which is located on the X chromosome. The IKBKG/NEMO protein plays a critical role in a signaling pathway called NF-kB, which is essential for activating immune cells to fight infections. When this protein does not work properly, the body's ability to produce certain protective immune signals, particularly interferon-gamma, is impaired. Because the gene is on the X chromosome, this condition primarily affects boys and men. Note that this Orphanet entry is marked as 'OBSOLETE,' meaning it may have been reclassified or merged into a broader category of MSMD or NEMO deficiency syndromes. Patients and families should discuss the most current classification with their geneticist. Symptoms typically appear in early childhood and include severe or recurrent mycobacterial infections, which can affect the lungs, lymph nodes, bones, and skin. Treatment focuses on aggressive antibiotic therapy for infections and may include interferon-gamma supplementation. In severe cases, bone marrow transplantation may be considered. Early diagnosis and ongoing immune monitoring are essential for improving outcomes.

Also known as:

Key symptoms:

Severe or recurrent infections caused by mycobacteria (including BCG vaccine reactions)Swollen lymph nodesPersistent feversLung infections or pneumoniaBone infections (osteomyelitis)Skin infections or abscessesPoor weight gain or failure to thriveChronic diarrheaFatigue and general weaknessInfections that do not respond well to standard antibioticsSusceptibility to other unusual infections (fungal, viral)Abnormal skin findings such as a condition called ectodermal dysplasia in some NEMO-related cases

Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency.

View clinical trials →

No actively recruiting trials found for OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency community →

No specialists are currently listed for OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiencyForum →

No community posts yet. Be the first to share your experience with OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency.

Start the conversation →

Latest news about OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency

No recent news articles for OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific mutation was found in the IKBKG gene, and what does it mean for my child's immune function?,Should my child receive interferon-gamma therapy, and what are the benefits and risks?,Is bone marrow transplantation an option for my child, and when would it be considered?,Which vaccines are safe and which should be avoided?,What signs of infection should prompt an emergency room visit?,Are other family members at risk, and should they be tested?,Are there any clinical trials or new treatments being studied for this condition?

Common questions about OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency

What is OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency?

X-linked Mendelian Susceptibility to Mycobacterial Diseases (MSMD) due to IKBKG deficiency is a rare inherited immune system disorder that makes affected individuals highly vulnerable to infections caused by mycobacteria. Mycobacteria are a group of germs that include the bacteria responsible for tuberculosis (TB) and other normally weak (low-virulence) organisms like BCG vaccine strains and environmental mycobacteria. In healthy people, the immune system can usually fight off these germs easily, but in people with this condition, the immune system cannot mount an effective defense. This cond

How is OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency inherited?

OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency typically begin?

Typical onset of OBSOLETE: X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency is infantile. Age of onset can vary across affected individuals.